AN2 Therapeutics, Inc. (ANTX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$2.97
Day's range
$6.91

AN2 Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VIVO CAPITAL, LLC 05/20/2026 3.15 M $10.79 M   100.00% 10.44%
COMMODORE CAPITAL LP 05/15/2026 2.33 M $7.98 M   100.00% 7.72%
MILLENNIUM MANAGEMENT LLC 05/15/2026 2.22 M $7.60 M   2,222.78% 7.36%
05/14/2026 1.66 M $5.58 M   100.00% 5.50%
ALMITAS CAPITAL LLC 05/15/2026 1.48 M $5.06 M   0.00% 4.90%
05/15/2026 1.01 M $3.46 M   100.00% 3.35%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2026 1.00 M $3.42 M   100.00% 3.31%
WOODLINE PARTNERS LP 05/15/2026 993.67 K $3.40 M   580.73% 3.29%
BOXER CAPITAL MANAGEMENT, LLC 05/15/2026 749.04 K $2.56 M   100.00% 2.48%
STONEPINE CAPITAL MANAGEMENT, LLC 05/14/2026 713.85 K $2.44 M   13.73% 2.36%
AMERIPRISE FINANCIAL INC 05/15/2026 696.18 K $2.38 M   100.00% 2.30%
SIO CAPITAL MANAGEMENT, LLC 05/14/2026 657.20 K $2.25 M   100.00% 2.18%
ALLY BRIDGE GROUP (NY) LLC 05/18/2026 526.32 K $1.80 M   100.00% 1.74%
PROSIGHT MANAGEMENT, LP 05/15/2026 515.75 K $1.76 M   100.00% 1.71%
BANK OF NOVA SCOTIA 05/14/2026 459.19 K $1.57 M   0.00% 1.52%
BANK OF AMERICA CORP /DE/ 05/18/2026 393.70 K $1.35 M   2.18% 1.30%
BLACKROCK, INC. 05/13/2026 318.77 K $1.09 M   -1.41% 1.06%
JANE STREET GROUP, LLC 05/12/2026 303.65 K $1.04 M   1,593.05% 1.00%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 05/12/2026 298.17 K $1.02 M   -30.94% 0.99%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 286.55 K $980.84 K   13.77% 0.95%
BANK OF MONTREAL /CAN/ 05/13/2026 260.13 K $889.63 K   -38.37% 0.86%
MORGAN STANLEY 05/15/2026 234.19 K $800.92 K   1.92% 0.78%
CANTOR FITZGERALD, L. P. 05/15/2026 200.00 K $684.00 K   100.00% 0.66%
06/04/2026 199.70 K $682.98 K   100.00% 0.66%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 198.80 K $679.90 K   -41.29% 0.66%
CITADEL ADVISORS LLC 05/15/2026 155.24 K $530.92 K   34.36% 0.51%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 137.71 K $470.96 K   100.00% 0.46%
STATE STREET CORP 05/15/2026 115.20 K $393.99 K   32.41% 0.38%
CENTIVA CAPITAL, LP 05/14/2026 75.00 K $256.50 K   100.00% 0.25%
UBS GROUP AG 05/05/2026 61.39 K $209.96 K   8.34% 0.20%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 05/15/2026 59.90 K $204.86 K   0.00% 0.20%
PEAPOD LANE CAPITAL LLC 05/04/2026 59.85 K $206.90 K   -89.91% 0.20%
NORTHERN TRUST CORP 05/14/2026 43.20 K $147.73 K   0.00% 0.14%
CAPTRUST FINANCIAL ADVISORS 05/15/2026 40.00 K $136.80 K   0.00% 0.13%
PERSISTENT ASSET PARTNERS LTD 05/12/2026 38.16 K $130.49 K   100.00% 0.13%
HUDSON BAY CAPITAL MANAGEMENT LP 05/13/2026 34.61 K $118.35 K   100.00% 0.11%
HRT FINANCIAL LP 05/14/2026 32.92 K $112.00 K   100.00% 0.11%
BNP PARIBAS ARBITRAGE, SNC 05/12/2026 30.08 K $102.87 K   9,826.73% 0.10%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 24.17 K $82.66 K   137.31% 0.08%
XTX TOPCO LTD 05/15/2026 22.40 K $76.62 K   100.00% 0.07%
CITIGROUP INC 05/11/2026 19.09 K $65.28 K   100.00% 0.06%
MARSHALL WACE, LLP 05/15/2026 17.70 K $60.53 K   100.00% 0.06%
OMERS ADMINISTRATION CORP 05/15/2026 15.80 K $54.04 K   100.00% 0.05%
ADAR1 CAPITAL MANAGEMENT, LLC 05/18/2026 13.86 K $47.41 K   100.00% 0.05%
PRIVATE ADVISOR GROUP, LLC 04/27/2026 12.50 K $42.75 K   -44.44% 0.04%
FEDERATED HERMES, INC. 05/11/2026 8.32 K $28.46 K   -27.50% 0.03%
VANGUARD GLOBAL ADVISERS, LLC 05/08/2026 7.33 K $25.08 K   100.00% 0.02%
CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD 05/11/2026 2.60 K $8.89 K   100.00% 0.01%
TOWER RESEARCH CAPITAL LLC (TRC) 05/15/2026 574 $1.96 K   -71.86% 0.00%
BARCLAYS PLC 05/15/2026 400 $1.37 K   100.00% 0.00%

AN2 Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 63 institutional investors and hedge funds held shares of AN2 Therapeutics Inc. The most heavily invested institutionals were:

Vivo Capital, LLC: 3.15 M

COMMODORE CAPITAL LP: 2.33 M

MILLENNIUM MANAGEMENT LLC: 2.22 M

Almitas Capital LLC: 1.48 M

ADAGE CAPITAL PARTNERS GP, L.L.C.: 1,000,000

Woodline Partners LP: 993,671

72.46% of AN2 Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 20.70 M shares in the last 24 months. This purchase volume represents approximately $108.68 M in transactions.